Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization

American Journal of Epidemiology

Volumn 171, Issue 3, 2010, Pages 357-367

  Chao, Chun ^a   Velicer, Christine ^b   Slezak, Jeff M ^a   Jacobsen, Steven J ^a  

^a Kaiser Permanente Southern California ^*  (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Female; Human papillomavirus 11; Human papillomavirus 16; Human papillomavirus 18; Human papillomavirus 6; Managed care programs; Papillomavirus vaccines; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENCE; HEALTH POLICY; HEALTH RISK; HEALTH SERVICES; IMMUNE SYSTEM; SEXUALLY TRANSMITTED DISEASE; SOCIOECONOMIC CONDITIONS; VACCINATION; WOMENS HEALTH;

ADOLESCENT; ADULT; ARTICLE; CHILD; ETHNICITY; FEMALE; GROUPS BY AGE; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INFLUENZA VACCINATION; MANAGED CARE ORGANIZATION; PRESCHOOL CHILD; PROPHYLAXIS; SCHOOL CHILD; SEXUALLY TRANSMITTED DISEASE; VERRUCA VULGARIS;

ADOLESCENT; ADULT; CHILD; DEMOGRAPHY; FEMALE; GAMMAPAPILLOMAVIRUS; HEALTH STATUS; HUMANS; MANAGED CARE PROGRAMS; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS VACCINES; VACCINATION; YOUNG ADULT;

CALIFORNIA; UNITED STATES;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS - 18; HUMAN PAPILLOMAVIRUS - 6; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; PAPILLOMAVIRIDAE;

EID: 75149169736     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp365     Document Type: Article

References (20)

1. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6(5):271-278.
2. Villa LL, Costa RL, Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer. 2006;95(11):1459- 1466.
3. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24.
4. Liu T, Wang X, Waterbor JW, et al. Relationships between socioeconomic status and race-specific cervical cancer incidence in the United States, 1973-1992. J Health Care Poor Underserved. 1998;9(4):420-432.
5. McDougall JA, Madeleine MM, Daling JR, et al. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control. 2007; 18(10):1175-1186.
6. Chen W, Petitti DB, Enger S. Limitations and potential uses of census-based data on ethnicity in a diverse community. Ann Epidemiol. 2004;14(5):339-345.
7. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons; 1987
8. Screening for cervical cancer: recommendations and rationale. Am Fam Physician. 2003;67(8):1759-1766.
9. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7): 702-706
10. Centers for Disease Control and Prevention (CDC). Vaccination coverage among adolescents aged 13-17 years-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(40): 1100-1103.
11. Grant D, Kravitz-Wirtz N, Breen N, et al. One in four California adolescent girls have had human papillomavirus vaccination (Report). Policy Brief UCLA Cent Health Policy Res. 2009;(PB2009-3):1-6.
12. Kahn JA, Zimet GD, Bernstein DI, et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health. 2005;37(6):502-510.
13. Kahn JA, Rosenthal SL, Tissot AM, et al. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr. 2007;7(5):367-373.
14. Mays RM, Zimet GD. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sex Transm Dis. 2004;31(7):428-432.
15. Riedesel JM, Rosenthal SL, Zimet GD, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol. 2005;18(6):391-398.
16. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43(3): 239-245.
17. Chao C, Slezak JM, Coleman KJ, et al. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health. 2009;99(6): 1137-1142.
18. Kiefe CI, Funkhouser E, Fouad MN, et al. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med. 1998;13(6):357-365.
19. Jiménez-Morales S, Velázquez-Cruz R, Raḿirez-Bello J, et al. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol. 2009;70(4):251-256.
20. Hemminki K, Li X, Sundquist J, et al. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum. 2009;60(3):661-668.